Form Type: 4

SEC EDGAR Link
Accession Number:0001104659-22-004129
Date:2022-01-12
Issuer: ENTRADA THERAPEUTICS, INC. (TRDA)
Original Submission Date:

Reporting Person:

CROWLEY JOHN F
C/O ENTRADA THERAPEUTICS, INC.
6 TIDE STREET BOSTON, MA 02210

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2022-01-12 P 5,000 a $9.72 5,000 direct
COMMON STOCK 2022-01-12 0 $0.00 32,864 indirect f1
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 consists of (i) 19,171 shares of common stock and (ii) 13,693 shares of restricted common stock issued upon early exercise of stock options held by john f. crowley 2021 family trust. john f. crowley exercises voting and dispositive power over the shares beneficially owned by john f. crowley 2021 family trust.
WhaleWisdom Logo

Elevate your investments